Monitoring nicotine intake in human volunteers transitioning from cigarette smoking to e-cigarette use

Introduction:
Use of electronic cigarettes (ECs) has increased rapidly since they were introduced in Europe in 2006 especially in the UK. Claims have been made for a role in tobacco harm reduction and smoking cessation. Key to these claims is the ability of EC to maintain nicotine levels to limit cravings, withdrawal and nicotine dependence. Therefore, the aim of the current study is to monitor nicotine intake in heavy smokers (>10 cig/day, n=13 completed) transitioning from cigarette smoking to EC-only use whilst collecting psychometric data on nicotine dependence (Fagerstrom), withdrawal (Minnesota), anxiety, depression and sleep quality.

Material and Methods:
Urine and saliva samples as well as psychometric questionnaire data were collected at baseline (visits 1 and 2) and at days 3, 7, 21 and 28 following start of EC use. An UHPLC-HESI-HRMS method was developed, validated and applied to the determination of nicotine and its main metabolite cotinine in urine and saliva.

Results:
The baseline median (interquartile range) urinary nicotine and cotinine levels were determined as 1534 ng/mg creatinine (317-2478) and 2082 ng/mg creatinine (1727-3632), whereas salivary nicotine and cotinine levels were 145 ng/ml (26-265) and 329 ng/ml (198-440), respectively. One-way repeated measures Anova demonstrated a significant decrease in urinary nicotine and cotinine concentration from baseline at 3 post-transition visits. A significant reduction was also observed in salivary nicotine levels on days 3 and 21 after EC transition and in salivary cotinine levels at each post-transition visit compared to baseline. Both urge and strength of urges to smoke were significantly decreased by 28days compared to baseline.

Conclusions:
These findings offer support that EC can be effective in reducing nicotine consumption and cravings for cigarettes, suggesting the potential use of EC as a smoking cessation tool. However, the inability to achieve levels of nicotine comparable to smokers may contribute to relapse.

Funding Statement:
Funded by European Commission Horizon 2020 programme.

CITATIONS (1):

A Summary of In Vitro and In Vivo Studies Evaluating the Impact of E-Cigarette Exposure on Living Organisms and the Environment
Anna Merecz-Sadowska, Przemyslaw Sitarek, Hanna Zielinska-Blizniewska, Katarzyna Malinowska, Karolina Zajdel, Lukasz Zakonnik, Radoslaw Zajdel
International Journal of Molecular Sciences

CrossRef

Submit your paper

Instructions to Authors

Home

Send by email

Patient–provider communication about cigarette and e-cigarette use during pregnancy: Adaptation and validation of frequency and quality of communication measures among a sample of pregnant patients

Session on tobacco and e-cigarette use and urological cancers: major conclusions on the risk, beliefs and behaviors, preventive recommendations

E-cigarette use and the potential risk for bladder cancer

Perceived content, relationship with tobacco and self-reported reasons for e-cigarette use among adolescents in Europe - findings from ESPAD 2019

A scoping review on e-cigarette environmental impacts

Indexes

Keywords index

Topics index

Authors index

On behalf of the European Network of Smoking and Tobacco Prevention. Chausse d'lxelles 144, Brussels, Belgium.
Published by European Publishing. Science and Technology Park of Crete (STEP-C). Vassilika Vouton, GR-70013 Heraklion, Crete, Greece

This journal is currently funded by the Health Programme of the European Union
Neither the European Commission nor any person acting on behalf of the European Commission is responsible for the use which might be made of the information contained herein. The views in this publication are those of the author and do not necessarily reflect the policies of the European Commission.

© 2024 European Publishing, unless otherwise stated.
The views and opinions expressed in the published articles are strictly those of the author(s). 21 December 2021.